Showing results (471-480 of 1,584) with videos related to
Sort By:
Pageof 159
BMC Research Notes|November 14, 2009
Media acidification by Escherichia coli in the presence of cranberry juiceBrandy J Johnson, Baochuan Lin, Robert A Rubin, et al.Anaerobe|November 28, 2012
Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case seriesTimothy A Rubin, Charles E Gessert, Johannes Aas, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1986
Nizatidine, an H2-blocker. Its metabolism and disposition in manM P Knadler, R F Bergstrom, J T Callaghan, et al.Prostate Cancer and Prostatic Diseases|April 5, 2017
Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?V R Minciacchi, A Zijlstra, M A Rubin, et al.BMC Evolutionary Biology|January 25, 2013
Impact of constitutional copy number variants on biological pathway evolutionMaria Poptsova, Samprit Banerjee, Omer Gokcumen, et al.Neoplasia (New York, N.Y.)|April 28, 2001
Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysisH Chaib, E K Cockrell, M A Rubin, et al.Archives of Pathology & Laboratory Medicine|July 10, 2007
A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinomaRonald J Cohen, Thomas M Wheeler, Helmut Bonkhoff, et al.The Lancet. Gastroenterology & Hepatology|June 13, 2018
Safely reprocessing duodenoscopes: current evidence and future directionsZachary A Rubin, Stephen Kim, Adarsh M Thaker, et al.International Journal of Sports Medicine|February 10, 2009
Footwear and running cardio-respiratory responsesD A Rubin, R J Butler, B Beckman, et al.JCO Precision Oncology|October 29, 2021
PARP Inhibition in Prostate Cancer With Homologous Recombination Repair AlterationsAlexander von Werdt, Laura Brandt, Orlando D Schärer, et al.Pageof 159